Acute infectious purpura fulminant due to Enterococcus faecium infection: a case report
- PMID: 40350462
- PMCID: PMC12067727
- DOI: 10.1186/s13256-025-05160-y
Acute infectious purpura fulminant due to Enterococcus faecium infection: a case report
Abstract
Background: Purpura fulminant is a rare life-threatening disorder characterized by a dysregulated response that is often associated with poor prognosis and lethal outcomes. It is often associated with disseminated intravascular coagulation, skin necrosis, and protein C deficiency leading to thrombotic occlusion of skin arterioles, causing palpable purpuric lesions, spreading ecchymosis, and gangrene, along with hypotension and fever. Purpura fulminant is classified into three distinct categories according to the trigger mechanisms, including neonatal, idiopathic, and acute infectious. Acute infectious purpura fulminant is the most common manifestation, which occurs after bacterial infections caused by acquired protein C deficiency. Although traditionally occurring in Neisseria meningitidis infection and Streptococcus infection, acquired protein C deficiency causing purpura fulminant due to Enterococcus faecium has not been described in the literature. This case report highlights the fact that purpura fulminans can also be a rare presentation of Entercoccus faecium infection.
Case presentation: A 61-year-old Arab man who is immunocompetent presented with sepsis, which later escalated into septic shock due to Enterococcus faecium bacteremia. The patient's hospitalization rapidly developed into multiorgan dysfunction, disseminated intravascular coagulation, and purpura fulminans. Aggressive interventions were initiated, involving the administration of broad-spectrum antibiotics, multiple vasopressors, and mechanical ventilation. Despite these intensive measures, the patient ultimately succumbed to the complications of multiorgan failure and death.
Conclusion: This case illustrates the devastating outcomes that can present from purpura fulminant. However, physicians should consider purpura fulminant caused by Enterococcus faecium infection in the workup of patients presenting with purpuric rash and fever.
Keywords: Enterococcus faecium; Acute infectious purpura fulminant; Disseminated intravascular coagulation.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests: The authors declare that they have no competing interests.
Figures
Similar articles
-
Purpura Fulminans: A rare presentation of Streptococcus Pneumoniae infection.BMJ Case Rep. 2017 Oct 20;2017:bcr2017221150. doi: 10.1136/bcr-2017-221150. BMJ Case Rep. 2017. PMID: 29054893 Free PMC article.
-
Septic Shock and Purpura Fulminans Due to Streptococcus pneumoniae Bacteremia in an Unvaccinated Immunocompetent Adult: Case Report and Review.Am J Case Rep. 2020 Jun 9;21:e923266. doi: 10.12659/AJCR.923266. Am J Case Rep. 2020. PMID: 32513908 Free PMC article. Review.
-
Pneumococcal sepsis-induced purpura fulminans in an asplenic adult patient without disseminated intravascular coagulation.Am J Med Sci. 2013 Dec;346(6):514-6. doi: 10.1097/MAJ.0b013e31829e02d3. Am J Med Sci. 2013. PMID: 24185261
-
Refractory gram-negative septic shock complicated by extended purpura fulminans and multiple organ failure in a 23-year-old puerpera -a case report.Korean J Anesthesiol. 2021 Jun;74(3):266-270. doi: 10.4097/kja.20201. Epub 2020 Jul 21. Korean J Anesthesiol. 2021. PMID: 32689761 Free PMC article.
-
Streptococcus pyogenes-purpura fulminans as an invasive form of group A streptococcal infection.Ann Clin Microbiol Antimicrob. 2018 Jul 9;17(1):31. doi: 10.1186/s12941-018-0282-9. Ann Clin Microbiol Antimicrob. 2018. PMID: 29986727 Free PMC article. Review.
References
-
- Contou D, de Prost N. Purpura fulminans in adult patients. Rev Prat. 2023;73(1):71–8. - PubMed
-
- Spicer TE, Rau JM. Purpura fulminans. Am J Med. 1976;61(4):566–71. - PubMed
-
- White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood. 2000;96(12):3719–24. - PubMed
-
- Chalmers E, Cooper P, Forman K, Grimley C, Khair K, Minford A, Morgan M, Mumford AD. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child. 2011;96(11):1066–71. - PubMed
-
- Chu DZ, Blaisdell FW. Purpura fulminans. Am J Surg. 1982;143(3):356–62. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources